Podcast Overview
<p>A podcast exploring biotech, technology, business, pharma, science and everything in between! </p>
Language
🇺🇲
Publishing Since
11/9/2025
1 verified contact email on file for Après Venture
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
December 8, 2025
Rauno Oja
<p><b>Transforming Clinical Research – Insights from Rauno Oja, CEO of EGeen International Corporation</b></p><p></p><p>In this episode, Rauno Oja, CEO of EGeen International Corporation, shares his distinctive perspective on the pharmaceutical and clinical research industry. With a background in business administration rather than medicine, Rauno entered the sector immediately after graduation and has since built one of Europe’s fastest-growing contract research organizations (CROs).</p><p></p><p>Rauno discusses the persistent inefficiencies that frustrate him most in clinical trials, the limitations of technology when applied without clear strategy, and why AI alone cannot solve the industry’s challenges. He explains that true acceleration comes from direction first, tools second.</p><p></p><p>Key topics include:</p><p></p><ul><li>EGeen’s evolution from an Estonian genome initiative to a full-service European CRO offering feasibility, site selection, regulatory support, patient recruitment, monitoring, project management, data management, biostatistics, and medical writing</li><li>The strategic advantage of maintaining on-site monitoring and building genuine investigator relationships in an increasingly remote industry</li><li>How early, collaborative feasibility and mock protocol exercises with sites prevent costly delays and amendments</li><li>Proven success in outperforming larger competitors in patient enrollment speed and volume</li><li>A balanced view on AI and digital tools: powerful enablers when guided by experience and clear objectives<p></p></li></ul><p>Rauno demonstrates that diverse leadership backgrounds, proactive site partnership, and disciplined use of technology can deliver faster, higher-quality clinical trials without compromising standards.</p><p></p><p>Ideal for clinical operations leaders, sponsor teams, investigators, and anyone seeking practical ways to improve trial efficiency and outcomes.</p><p></p><p><b>Tags:</b> pharmaceutical, clinical research, CRO, patient recruitment, site engagement, trial efficiency, AI in clinical trials, Rauno Oja, EGeen International Corporation, clinical operations, feasibility studies, monitoring, biotech</p>
December 1, 2025
Marc Teitelbaum
<p><b>Summary </b></p><p></p><p>In this episode of the Après Venture Podcast, host Finith Jernigan sits down with Marc Teitelbaum, co-founder of Prognostic Optimization Group (POG AI).</p><p></p><p>Marc shares his unconventional path from EMT and premed to biotech consulting, a PhD in regenerative medicine, drug development startups, and ultimately founding POG AI after a frustrating doctor’s visit wait time.</p><p></p><p>He explains how POG AI uses intelligent patient triage and chat-based intake to create comprehensive SOAP notes, reduce physician burnout, cut wait times, and empower patients with centralized health records and longitudinal insights.</p><p></p><p>Marc discusses current seed fundraising ($1.5M target), plans for Epic/Athena health integration, specialty-specific customization (e.g., ADHD), and the broader vision of making patients the quarterback of their own healthcare.</p><p></p><p>A candid conversation on AI in healthcare, physician pain points, patient experience, and building a patient-centered health platform in today’s fragmented system.</p><p></p><p><b>Takeaways</b></p><p></p><ul><li>Healthcare data is often not aggregated across different specialists.</li><li>Patients lack a comprehensive view of their health history.</li><li>The inefficiency of the healthcare marketplace is a significant issue.</li><li>HIPAA privacy regulations create barriers to data sharing.</li><li>Personal experiences can drive innovation in healthcare.</li><li>Long wait times for simple procedures frustrate patients.</li><li>There are both flaws and positive aspects in the healthcare system.</li><li>Stakeholders in healthcare complicate the efficiency of services.</li><li>Innovative solutions are needed to improve patient experiences.</li><li>The conversation highlights the importance of data in healthcare.</li></ul><p></p><p><b>Keywords </b></p><p></p><p>healthcare, data aggregation, patient experience, innovation, HIPAA, healthcare system flaws</p><p></p>
November 20, 2025
Anthony Mazzotti
<p>This episode of the Après Venture Podcast delves into the intricacies of chemical reactions, focusing on selectivity and the challenges faced in chemical synthesis. The discussion highlights innovative approaches in chemical research, including the use of deuterated solvents and NMR techniques to achieve better outcomes in reactions. The conversation also touches on future directions in the field of chemistry, emphasizing the importance of overcoming obstacles to enhance research and development.</p><p></p><p>Takeaways</p><ul><li>The importance of selectivity in chemical reactions.</li><li>Challenges often arise in chemical synthesis processes.</li><li>Innovative techniques can lead to better results in chemistry.</li><li>Deuterated solvents play a crucial role in NMR analysis.</li><li>Understanding the reaction mechanism is key to troubleshooting.</li><li>Collaboration and communication are vital in research settings.</li><li>Continuous learning is essential for chemists.</li><li>Future research should focus on overcoming existing challenges.</li><li>The role of oxidants in chemical reactions is significant.</li><li>Innovations in chemistry can lead to groundbreaking discoveries.</li></ul><p></p><p>Keywords</p><p></p><p>chemical reactions, selectivity, synthesis, innovations, research, chemistry, NMR, oxidants, deuterated solvent, functionalization</p>
8 total episodes available
Deep-dive analytics for Après Venture
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Après Venture?
<p>A podcast exploring biotech, technology, business, pharma, science and everything in between! </p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.